Celgene Corporation (NASDAQ: CELG) will host a conference call and live
audio webcast on Thursday, October 26, 2017 at 9 a.m. ET to discuss
third quarter 2017 financial and operational results. The webcast can be
accessed from the Investor Relations page at www.celgene.com.
Celgene will also host a webcast of an investor event at the
MSParis2017–7th Joint European Committee for Treatment and Research in
Multiple Sclerosis (ECTRIMS) – American Committee for Treatment and
Research in Multiple Sclerosis (ACTRIMS) Meeting on Saturday, October 28
at 6:00 p.m. CEST (12:00 p.m. ET). Members of Celgene’s management team
and clinical investigators will discuss the data presentations at the
ECTRIMS Meeting. The event will be webcast live and will be available in
the Investor Relations section of the Company’s web site at www.celgene.com.
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in the
discovery, development and commercialization of innovative therapies for
the treatment of cancer and inflammatory diseases through
next-generation solutions in protein homeostasis, immuno-oncology,
epigenetics, immunology and neuro-inflammation. For more information,
please visit www.celgene.com.
Follow Celgene on Social Media: @Celgene,
This press release contains forward-looking statements, which are
generally statements that are not historical facts. Forward-looking
statements can be identified by the words "expects," "anticipates,"
"believes," "intends," "estimates," "plans," "will," “outlook” and
similar expressions. Forward-looking statements are based on
management’s current plans, estimates, assumptions and projections, and
speak only as of the date they are made. We undertake no obligation to
update any forward-looking statement in light of new information or
future events, except as otherwise required by law. Forward-looking
statements involve inherent risks and uncertainties, most of which are
difficult to predict and are generally beyond our control. Actual
results or outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of
factors, many of which are discussed in more detail in our Annual Report
on Form 10-K and our other reports filed with the Securities and
Hyperlinks are provided as a convenience and for informational
purposes only. Celgene bears no responsibility for the security or
content of external websites.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171002005698/en/